Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions

Molecular Immunology

Volumn 46, Issue 14, 2009, Pages 2767-2773

  Erdei, Anna ^a   Isaák, Andrea ^a   Török, Katalin ^a   Sándor, Noémi ^a   Kremlitzka, Mariann ^a   Prechl, József ^a   Bajtay, Zsuzsa ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Autoimmunity; B and T lymphocytes; Complement receptors; CR1 (CD35); CR2 (CD21); Immune response

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE DISEASE; B LYMPHOCYTE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; T-LYMPHOCYTES;

EID: 68049148352     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.05.181     Document Type: Review

References (81)

1. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
2. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., and Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19 (1998) 56-59
3. Bottoa, M., Kirschfinkb, M., Macorc, P., Pickeringa, M.C., Würznerd, R., Tedescoc, F., this issue. Complement in human diseases: Lessons from complement deficiencies. Mol. Immunol. doi:10.1016/j.molimm.2009.04.029
4. Braun A., Sis J., Max R., Mueller K., Fiehn C., Zeier M., and Andrassy K. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Scand. J. Rheumatol. 36 (2007) 291-298
5. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16 (1998) 545-568
6. Castellano G., Woltman A.M., Schlagwein N., Xu W., Schena F.P., Daha M.R., and van K.C. Immune modulation of human dendritic cells by complement. Eur. J. Immunol. 37 (2007) 2803-2811
7. Cherukuri A., Cheng P.C., Sohn H.W., and Pierce S.K. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14 (2001) 169-179
8. Cohen J.H., Aubry J.P., Revillard J.P., Banchereau J., and Kazatchkine M.D. Human T lymphocytes expressing the C3b/C4b complement receptor type one (CR1, CD35) belong to Fc gamma receptor-positive CD4-positive T cells. Cell. Immunol. 121 (1989) 383-390
9. Craig M.L., Waitumbi J.N., and Taylor R.P. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. J. Immunol. 174 (2005) 3059-3066
10. Danielsson C., Pascual M., French L., Steiger G., and Schifferli J.A. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur. J. Immunol. 24 (1994) 2725-2731
11. Delibrias C.C., Kazatchkine M.D., and Fischer E. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand. J. Immunol. 38 (1993) 183-189
12. Delibrias C.C., Mouhoub A., Fischer E., and Kazatchkine M.D. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus. Eur. J. Immunol. 24 (1994) 2784-2788
13. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., and Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271 (1996) 348-350
14. Duddy M.E., Alter A., and Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation?. J. Immunol. 172 (2004) 3422-3427
15. Dykman T.R., Cole J.L., Iida K., and Atkinson J.P. Structural heterogeneity of the C3b/C4b receptor (Cr 1) on human peripheral blood cells. J. Exp. Med. 157 (1983) 2160-2165
16. Dykman T.R., Cole J.L., Iida K., and Atkinson J.P. Polymorphism of human erythrocyte C3b/C4b receptor. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 1698-1702
17. Elward K., Griffiths M., Mizuno M., Harris C.L., Neal J.W., Morgan B.P., and Gasque P. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280 (2005) 36342-36354
18. Erdei A., Prechl J., Isaak A., and Molnar E. Regulation of B-cell activation by complement receptors CD21 and CD35. Curr. Pharm. Des. 9 (2003) 1849-1860
19. Fang Y., Xu C., Fu Y.X., Holers V.M., and Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160 (1998) 5273-5279
20. Fingeroth J.D., Weis J.J., Tedder T.F., Strominger J.L., Biro P.A., and Fearon D.T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 4510-4514
21. Fischer E., Delibrias C., and Kazatchkine M.D. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146 (1991) 865-869
22. Fischer M.B., Ma M., Hsu N.C., and Carroll M.C. Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. J. Immunol. 160 (1998) 2619-2625
23. Grattone M.L., Villiers C.L., Villiers M.B., Drouet C., and Marche P.N. Co-operation between human CR1 (CD35) and CR2 (CD21) in internalization of their C3b and iC3b ligands by murine-transfected fibroblasts. Immunology 98 (1999) 152-157
24. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., and Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104 (2004) 2840-2848
25. Helmy K.Y., Katschke Jr. K.J., Gorgani N.N., Kljavin N.M., Elliott J.M., Diehl L., Scales S.J., Ghilardi N., and van Lookeren C.M. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124 (2006) 915-927
26. Henderson A.L., Lindorfer M.A., Kennedy A.D., Foley P.L., and Taylor R.P. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model. J. Immunol. Methods 270 (2002) 183-197
27. Heyzer-Williams L.J., and Heyzer-Williams M.G. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23 (2005) 487-513
28. Illges H., Braun M., Peter H.H., and Melchers I. Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes. Clin. Exp. Immunol. 122 (2000) 270-276
29. Isaak A., Gergely Jr. P., Szekeres Z., Prechl J., Poor G., Erdei A., and Gergely J. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients. Int. Immunol. 20 (2008) 185-192
30. Isaak A., Prechl J., Gergely J., and Erdei A. The role of CR2 in autoimmunity. Autoimmunity 39 (2006) 357-366
31. Jacobson A.C., and Weis J.H. Comparative functional evolution of human and mouse CR1 and CR2. J. Immunol. 181 (2008) 2953-2959
32. Jozsi M., Prechl J., Bajtay Z., and Erdei A. Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes. J. Immunol. 168 (2002) 2782-2788
33. Kavai M. Immune complex clearance by complement receptor type 1 in SLE. Autoimmun. Rev. 8 (2008) 160-164
34. Kerekes K., Prechl J., Bajtay Z., Jozsi M., and Erdei A. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int. Immunol. 10 (1998) 1923-1930
35. Klaus G.G., and Kunkl A. The role of germinal centres in the generation of immunological memory. Ciba Found. Symp. 84 (1981) 265-280
36. Klein U., Kuppers R., and Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 89 (1997) 1288-1298
37. Klein U., Rajewsky K., and Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188 (1998) 1679-1689
38. Klickstein L.B., Wong W.W., Smith J.A., Weis J.H., Wilson J.G., and Fearon D.T. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J. Exp. Med. 165 (1987) 1095-1112
39. Kozono Y., Duke R.C., Schleicher M.S., and Holers V.M. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur. J. Immunol. 25 (1995) 1013-1017
40. Krych M., Clemenza L., Howdeshell D., Hauhart R., Hourcade D., and Atkinson J.P. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J. Biol. Chem. 269 (1994) 13273-13278
41. Krych M., Molina H., and Atkinson J.P. CD35: complement receptor type 1. J. Biol. Regul. Homeost. Agents 13 (1999) 229-233
42. Krych-Goldberg M., Hauhart R.E., Porzukowiak T., and Atkinson J.P. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors. J. Immunol. 175 (2005) 4528-4535
43. Kurtz C.B., O'Toole E., Christensen S.M., and Weis J.H. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144 (1990) 3581-3591
44. Lee Y., Haas K.M., Gor D.O., Ding X., Karp D.R., Greenspan N.S., Poe J.C., and Tedder T.F. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement. J. Immunol. 175 (2005) 8011-8023
45. Levy E., Ambrus J., Kahl L., Molina H., Tung K., and Holers V.M. T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 90 (1992) 235-244
46. Looney R.J., Anolik J., and Sanz I. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells. Lupus 13 (2004) 381-390
47. Lund F.E., Garvy B.A., Randall T.D., and Harris D.P. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8 (2005) 25-54
48. Marquart H.V., Svendsen A., Rasmussen J.M., Nielsen C.H., Junker P., Svehag S.E., and Leslie R.G. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 101 (1995) 60-65
49. Masilamani M., Kassahn D., Mikkat S., Glocker M.O., and Illges H. B cell activation leads to shedding of complement receptor type II (CR2/CD21). Eur. J. Immunol. 33 (2003) 2391-2397
50. Masilamani M., Nowack R., Witte T., Schlesier M., Warnatz K., Glocker M.O., Peter H.H., and Illges H. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis. Scand. J. Immunol. 60 (2004) 625-630
51. Masilamani M., von S.E., Bastmeyer M., and Illges H. T cell activation induced by cross-linking CD3 and CD28 leads to silencing of Epstein-Barr virus/C3d receptor (CR2/CD21) gene and protein expression. Immunobiology 206 (2002) 528-536
52. Melchers F., Erdei A., Schulz T., and Dierich M.P. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 317 (1985) 264-267
53. Mevorach D., Mascarenhas J.O., Gershov D., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188 (1998) 2313-2320
54. Miwa T., Zhou L., Kimura Y., Kim D., Bhandoola A., and Song W.C. Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry. Blood 113 (2009) 2684-2694
55. Molnar E., Erdei A., and Prechl J. Novel roles for murine complement receptors type 1 and 2. I. Regulation of B cell survival and proliferation by CR1/2. Immunol. Lett. 116 (2008) 156-162
56. Molnar E., Prechl J., and Erdei A. Novel roles for murine complement receptors type 1 and 2. II. Expression and function of CR1/2 on murine mesenteric lymph node T cells. Immunol. Lett. 116 (2008) 163-167
57. Mongini P.K., Vilensky M.A., Highet P.F., and Inman J.K. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2). J. Immunol. 159 (1997) 3782-3791
58. Morelli A.E., Larregina A.T., Shufesky W.J., Zahorchak A.F., Logar A.J., Papworth G.D., Wang Z., Watkins S.C., Falo Jr. L.D., and Thomson A.W. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101 (2003) 611-620
59. Nash J.T., Taylor P.R., Botto M., Norsworthy P.J., Davies K.A., and Walport M.J. Immune complex processing in C1q-deficient mice. Clin. Exp. Immunol. 123 (2001) 196-202
60. Navratil J.S., Liu C.C., and Ahearn J.M. Apoptosis and autoimmunity. Immunol. Res. 36 (2006) 3-12
61. Pittoni V., and Valesini G. The clearance of apoptotic cells: implications for autoimmunity. Autoimmun. Rev. 1 (2002) 154-161
62. Prodinger W.M. Complement receptor type two (CR2, CR21): a target for influencing the humoral immune response and antigen-trapping. Immunol. Res. 20 (1999) 187-194
63. Ravetch J.V., and Clynes R.A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16 (1998) 421-432
64. Reinagel M.L., and Taylor R.P. Transfer of immune complexes from erythrocyte CR1 to mouse macrophages. J. Immunol. 164 (2000) 1977-1985
65. Sadallah S., Hess C., Trendelenburg M., Vedeler C., Lopez-Trascasa M., and Schifferli J.A. Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients. Clin. Exp. Immunol. 131 (2003) 174-181
66. Saevarsdottir S., Steinsson K., Ludviksson B.R., Grondal G., and Valdimarsson H. Mannan-binding lectin may facilitate the clearance of circulating immune complexes-implications from a study on C2-deficient individuals. Clin. Exp. Immunol. 148 (2007) 248-253
67. Sauvageau G., Stocco R., Kasparian S., and Menezes J. Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes. J. Gen. Virol. 71 Pt 2 (1990) 379-386
68. Schmidt R.E., and Gessner J.E. Fc receptors and their interaction with complement in autoimmunity. Immunol. Lett. 100 (2005) 56-67
69. Schulze C., Munoz L.E., Franz S., Sarter K., Chaurio R.A., Gaipl U.S., and Herrmann M. Clearance deficiency-a potential link between infections and autoimmunity. Autoimmun. Rev. 8 (2008) 5-8
70. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., and Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192 (2000) 359-366
71. Tsoukas C.D., and Lambris J.D. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur. J. Immunol. 18 (1988) 1299-1302
72. Tsuiji M., Yurasov S., Velinzon K., Thomas S., Nussenzweig M.C., and Wardemann H. A checkpoint for autoreactivity in human IgM+ memory B cell development. J. Exp. Med. 203 (2006) 393-400
73. Tuveson D.A., Ahearn J.M., Matsumoto A.K., and Fearon D.T. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex. J. Exp. Med. 173 (1991) 1083-1089
74. Wagner C., Ochmann C., Schoels M., Giese T., Stegmaier S., Richter R., Hug F., and Hansch G.M. The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Mol. Immunol. 43 (2006) 643-651
75. Westerberg L.S., Klein C., and Snapper S.B. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency-lessons learned from monogenic disorders in mice and men. Curr. Opin. Immunol. 20 (2008) 646-654
76. Wilson J.G., Ratnoff W.D., Schur P.H., and Fearon D.T. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. 29 (1986) 739-747
77. Wilson J.G., Tedder T.F., and Fearon D.T. Characterization of human T lymphocytes that express the C3b receptor. J. Immunol. 131 (1983) 684-689
78. Wu X., Jiang N., Deppong C., Singh J., Dolecki G., Mao D., Morel L., and Molina H.D. A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus. J. Immunol. 169 (2002) 1587-1592
79. Yaskanin D.D., Thompson L.F., and Waxman F.J. Distribution and quantitative expression of the complement receptor type 1 (CR1) on human peripheral blood T lymphocytes. Cell. Immunol. 142 (1992) 159-176
80. Yaskanin D.D., and Waxman F.J. Expression of the CR1 receptor on human leukemia-derived CD4+ T cell lines. Cell. Immunol. 163 (1995) 139-147
81. Yurasov S., Hammersen J., Tiller T., Tsuiji M., and Wardemann H. B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1062 (2005) 165-174